Silicon Laboratories Inc.
Income Statement
| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $228.2M | $213.5M | $208.2M | $206.0M | $192.8M | $177.7M | $166.2M | $166.4M |
| Cost of Revenue | $87.5M | $86.5M | $76.1M | $87.0M | $84.7M | $79.9M | $76.0M | $76.1M |
| Gross Profit | $140.7M | $127.0M | $132.1M | $119.0M | $108.1M | $97.8M | $90.2M | $90.3M |
| Gross Margin | 61.6% | 59.5% | 63.4% | 57.8% | 56.1% | 55.0% | 54.3% | 54.3% |
| Operating Expenses | ||||||||
| Research & Development | $95.0M | $88.6M | $89.5M | $87.7M | $87.8M | $88.2M | $82.4M | $83.2M |
| SG&A Expense | $56.3M | $55.5M | $45.8M | $43.7M | $43.2M | $41.6M | $36.4M | $36.8M |
| Operating Income | $-10.7M | $-17.1M | $-3.3M | $-12.3M | $-22.9M | $-32.1M | $-28.6M | $-29.7M |
| Operating Margin | -4.7% | -8.0% | -1.6% | -6.0% | -11.9% | -18.1% | -17.2% | -17.9% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-8.4M | $-13.7M | $-534.0K | $-9.5M | $-19.3M | $-28.6M | $-25.9M | $-26.5M |
| Income Tax Expense | $2.2M | $2.2M | $2.2M | $414.0K | $2.5M | $1.9M | $-2.1M | $2.0M |
| Net Income | $-10.6M | $-15.9M | $-2.7M | $-9.9M | $-21.8M | $-30.5M | $-23.8M | $-28.5M |
| Net Margin | -4.6% | -7.4% | -1.3% | -4.8% | -11.3% | -17.1% | -14.3% | -17.1% |
| EPS (Basic) | $-0.32 | $-0.48 | $-0.07 | $-0.30 | $-0.67 | $-0.94 | $-0.72 | $-0.88 |
| EPS (Diluted) | $-0.32 | $-0.48 | $-0.07 | $-0.30 | $-0.67 | $-0.94 | $-0.72 | $-0.88 |
| Shares Outstanding (Basic) | 33.2M | 33.0M | 32.7M | 32.8M | 32.7M | 32.5M | 32.2M | 32.3M |
| Shares Outstanding (Diluted) | 33.2M | 33.0M | 32.7M | 32.8M | 32.7M | 32.5M | 32.2M | 32.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |